Cyclerion Therapeutics

North America Legal Chronicle. June 16, 2023

Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy

By Laura Testa

Hughes Hubbard & Reed LLP represented Cyclerion Therapeutics in the deal. Cyclerion Therapeutics (NASDAQ: CYCN) announced the company’s sale of the rights to two drugs used...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America. North America Legal Chronicle. June 21, 2021

Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

By Martina Bellini

Morgan Lewis represented Cyclerion Therapeutics in the transaction. Cyclerion Therapeutics Inc. closed a licensing agreement with Akebia Therapeutics Inc. for the development and commercialization of praliciguat,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Dawn Richard v. Sean Diddy Combs

Databricks’ $10 Billion Series J Financing Round

Cometa’s $12 Million Series A Funding Round

Granado’s Acquisition of Care Natural Beauty

Eletrobras and CGT Eletrosul’s Asset Swap Agreement with Copel and Copel GeT

Nexa’s Funding Round

Findos Investor GmbH’s Acquisition Of OMB Saleri S.p.A. From DeA Capital

Marlin Equity Partners’ Investment in Radar Healthcare

TotalEnergies’ Divestment Of 50% Stake In West Burton B

Africa50’s Acquisition of a Stake in Raya Data Center

National Egyptian Railway Industries Company’s EGP5 Billion Syndicated Loan

Harith InfraCo’s R6.5 Billion Acquisition of African Infrastructure Fund

Savola Group’s Rights Offering and Acquisition of Stake in Almarai Company

Aldar’s Acquisition of a Commercial Office Tower in the Dubai International Financial Centre

TAV Airports’ €342 Million Long-Term Financing For Ankara Esenboga Airport

Nippon Life Insurance Company’s $10.6 Billion Acquisition of Resolution Life

Oberoi Group’s Partnership with Grosvenor Properties

Sterlite Power’s Investment Round

Real Estate Attorney Janet Lindeman Rejoins Quarles Chicago Office as Partner

Foley & Lardner Names Jen Cafferty Patton as Chief Operating Officer & Rebecca Bradley as Chief Talent Officer

TARGET Grows With Hiring of New Professionals From Hi.Lex & RaffaelliSegreti

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Real Estate Attorney Janet Lindeman Rejoins Quarles Chicago Office as Partner

TARGET Grows With Hiring of New Professionals From Hi.Lex & RaffaelliSegreti

Boies Schiller Flexner Promotes Five to Partner

Cyclerion Therapeutics’ Sale of Medicine to Treat Mitochondrial Encephalopathy

Standard 1 Year Membership Required

Cyclerion Therapeutics’ Licensing Agreement With Akebia Therapeutics

Standard 1 Year Membership Required